Aadi Bioscience, Inc. (AADI) Tops Q3 EPS by 12c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.60), $0.12 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $5.96 million versus the consensus estimate of $6.62 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
• BofA cuts PG&E to Neutral as California wildfire reforms fall short